AzTrials
AzTrials

Effect of Food on Postprandial HyperglycemiaNCT03522896

Effect of Orange Juice on Glycemic Response

A study testing test meal 1, test meal 2 and test meal 3 in people with Effect of Food on Postprandial Hyperglycemia, run by University of Leeds at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Orange juice naturally contains high concentrations of hesperidin, which affects glucose absorption in in vitro experiments. This study is to test if hesperidin and other components of orange juice (not other sugars or organic acids) affect the post-prandial blood glucose concentration derived from sugars already… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
test meal 1, test meal 2 and test meal 3
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
1 siteUnited Kingdom
Study dates
30 Sep 2017to 27 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • fasting blood glucose below 5.9 mM

Who cannot join

  • fasting glucose above 6 mM pregnant

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Leeds

    Leeds, LS29JT

Other trials in United Kingdom

About this study

Official title: Effect of Hesperidin in Orange Juice on Glycemic Response in Healthy Volunteers

Orange juice naturally contains high concentrations of hesperidin, which affects glucose absorption in in vitro experiments. This study is to test if hesperidin and other components of orange juice (not other sugars or organic acids) affect the post-prandial blood glucose concentration derived from sugars already present in the orange juice.

Read the detailed description

Healthy volunteers will consume orange juice with added water or food-grade hesperidin.

Being tested
control, test meal 1, test meal 2, test meal 3

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • controlOther

    balancing sugars and organic acids

  • test meal 1Other

    orange juice plus hesperidin low dose

  • test meal 2Other

    orange juice plus hesperidin higher dose

  • test meal 3Other

    diluted orange juice plus hesperidin low dose

Study groups in NCT03522896
Study groupRoleWhat they receive
control mealPlacebo comparatorglucose, fructose, sucrose, malic acid and citric acid in water
Receives: Other: control
test meal 1Experimentalorange juice with added hesperidin (low dose)
Receives: Other: test meal 1
test meal 2Experimentalorange juice with added hesperidin (high dose)
Receives: Other: test meal 2
test meal 3Experimentaldiluted orange juice with added hesperidin
Receives: Other: test meal 3

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood glucose concentration

    iAUC/[glucose]max

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2018
  2. Study start30 Sep 2017
  3. Primary completion27 Jun 2018
  4. Study completion27 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03522896
Sponsor's protocol ID
MEEC15-044b
Status last verified
Jun 2018
First submitted
30 Apr 2018
Last updated
28 Jun 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing test meal 1, test meal 2 and test meal 3 in people with Effect of Food on Postprandial Hyperglycemia, run by University of Leeds at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood glucose concentration (time frame: 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in